Lobbying

National Alliance for Care at Home's latest lobbying report covers Q2 2026, at $610K. The four quarters Q4 2025–Q3 2026 total $1.9M. Its first report covers Q4 2022; the issues it reports most are Health Issues and Medicare/Medicaid.

National Alliance for Care at Home

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$1.9M
Last 4 quarters
vs last quarter
−100.0%
Q3 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

National Alliance for Care at Home lobbying by quarter
National Alliance for Care at Home lobbying by quarter
QuarterAmountReports
Q4 2022$250K1
Q1 2023$260K1
Q2 2023$250K1
Q3 2023$250K1
Q4 2023$240K1
Q1 2024$240K1
Q2 2024$240K1
Q3 2024$180K1
Q4 2024$180K1
Q1 2025$520K1
Q2 2025$530K1
Q3 2025$920K1
Q4 2025$750K1
Q1 2026$570K1
Q2 2026$610K1
Q3 2026$00

By issue

  • Health issues$2.6M · 15 reports
  • Medicare and Medicaid$2.6M · 15 reports
  • Labor, antitrust and workplace$450K · 6 reports
  • Veterans$440K · 2 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • Centers For Medicare and Medicaid Services (CMS)15 reports
  • HOUSE OF REPRESENTATIVES15 reports
  • SENATE15 reports
  • Health & Human Services, Dept of (HHS)9 reports
  • Drug Enforcement Administration (DEA)8 reports
  • Labor, Dept of (DOL)8 reports
  • Office of Management & Budget (OMB)5 reports
  • Executive Office of the President (EOP)2 reports

Firms it paid

Firm
In-houseNational Alliance for Care at Home$6M15 quarters

Former officials lobbying for it

Former position
HILLARY LOEFFLERCenters for Medicare & Medicaid Services, Senior Adviser in OL and CPI and Director in HHH; House Ways and Means Committee, Detailee; U.S. Government Accountability Office, Senior AnalystQ3 2025
LOGAN MATTHEW HOOVERLegislative Director for Rep. Tom ReedQ3 2025

Lobbying reports

Filed by
07/20for Q2In-house$610K
04/17for Q1In-house$570K
01/20for Q4 2025In-house$750K
25/10/20for Q3 2025In-house$920K
25/07/21for Q2 2025In-house$530K
25/04/21for Q1 2025In-house$520K
25/01/21for Q4 2024In-house$180K
24/10/18for Q3 2024In-house$180K
24/07/22for Q2 2024In-house$240K
24/04/19for Q1 2024In-house$240K
24/01/22for Q4 2023In-house$240K
23/10/20for Q3 2023In-house$250K
23/07/20for Q2 2023In-house$250K
23/04/20for Q1 2023In-house$260K
23/01/20for Q4 2022In-house$250K